URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology

ROCHESTER, N.Y. , Jan. 8 /PRNewswire-USNewswire/ -- The University of Rochester Medical Center (URMC) has received a U.S. patent for a diagnostic technology that can rapidly and accurately screen for organisms such as bacteria and other infectious...


About the University of Rochester Medical Center

One of the nation's top academic medical centers, the University of Rochester Medical Center (http://www.urmc.rochester.edu) forms the centerpiece of the University's health research, teaching, patient care, and community outreach missions. The Medical Center receives more than $230 million in external research funding per year, and the University of Rochester School of Medicine and Dentistry ranks in the top one-quarter of U.S. medical centers in federal research funding. The University's health care delivery network is anchored by Strong Memorial Hospital - a 739-bed, University-owned teaching hospital. As upstate New York's premier health care delivery network, patients benefit from the Medical Center's robust teaching and biomedical research programs.

About Lighthouse Biosciences, LLC

Lighthouse Biosciences, LLC is an early-stage, molecular in vitro diagnostic company located in Rochester, NY . Based on its proprietary NanoLantern(TM) platform, Lighthouse is developing breakthrough diagnostic solutions that are much faster, more accurate, simpler, and less expensive than currently used diagnostics. Additionally, the NanoLantern(TM) technology enables multiple tests on a single sample for simultaneous and very reliable results. Lighthouse solutions consist of "lab on chip" disposable cartridges that contain highly targeted detection probes and sample chemistry and a desktop reader workstation for preparing and presenting test results. Lighthouse expects its product solutions are small and simple enough to deploy throughout decentralized environments, like point-of-care healthcare locations, and are scalable to serve the high-volume needs of centralized laboratories.

SOURCE University of Rochester Medical Center